Problems persist for kids exposed to cannabis in the womb
Research from Ryan Bogdan’s BRAIN Lab in Arts & Sciences finds signs of psychopathology persist into mid-adolescence in kids exposed to cannabis in the womb.
Evaluation of AI for medical imaging: A key requirement for clinical translation
To develop guidelines to evaluate artificial intelligence (AI) in nuclear-medicine imaging, an interdisciplinary team established by Richard L. Wahl, MD, director of Mallinckrodt Institute of Radiology (MIR) and led by Abhinav Jha, assistant professor at the McKelvey School of Engineering, published Recommendations for Evaluation of AI for Nuclear Medicine in the Journal of Nuclear Medicine.
New practical method of producing Airy beams could enhance ultrasound
Researchers led by the McKelvey School of Engineering’s Hong Chen recently invented a technique for generating ultrasound waves that can self-bend, like a rainbow.
World’s first nasal COVID-19 vaccine approved in India; based on Washington University technology
The world’s first nasal vaccine for COVID-19 was approved Sept. 6 in India for emergency use. The vaccine, called iNCOVACC, is based on technology licensed from Washington University and developed in collaboration with Bharat Biotech International Limited in India.
Restoring movement after spinal cord injury focus of new research
Ismael Seáñez received a five-year $1 million grant from the National Institutes of Health (NIH) to lead interdisciplinary spinal cord injury research.
Low testosterone may increase risk of COVID-19 hospitalization for men
Men with low testosterone who develop COVID-19 are at elevated risk of becoming seriously ill and ending up in the hospital, according to a study by researchers at Washington University School of Medicine and Saint Louis University School of Medicine.
Simple blood test predicts neurotoxic complications of CAR-T cell therapy
A new study from Washington University School of Medicine suggests a simple blood test — administered before CAR-T cell treatment is initiated — may identify which patients are predisposed to developing neurotoxic side effects after CAR-T cell therapy, which is used to treat several cancers.
Faculty receive $6.1M NIH grant for maternal health study
Three faculty from the Brown School and School of Medicine at Washington University in St. Louis have received a seven-year $6.1 million grant from the National Institutes of Health (NIH) for a project aimed at improving the health of mothers and children in the St. Louis region.
Drug combo therapy in mice blocks drug resistance, halts tumor growth
An experimental combination of two drugs halts the progression of small cell lung cancer, the deadliest form of lung cancer, according to a study in mice from researchers at Washington University School of Medicine in St. Louis and colleagues.
New technology offers pathways to finding treatments for kidney disease
Research from the McKelvey School of Engineering and School of Medicine aims to overcome a critical barrier in kidney disease research with a new way to culture specific kidney cells.
Older Stories